Finally, reverse transcription quantitative polymerase chain reaction (RT-qPCR) was performed to validate biomarker expression levels in clinical samples.<h4>Results</h4>Through a comprehensive analysis of bioinformatics methods, we identified two biomarkers-PTGS2 and NFE2L2-as significant candidates in DN. This evidence concerns the gene NFE2L2 and liver dysplastic nodule.